UM  > Institute of Chinese Medical Sciences
Residential Collegefalse
Status已發表Published
Myricanol prevents aging-related Sarcopenia via targeting peroxiredoxin 5 and Nampt
LIN LIGEN
2024
Size of Audience50
Type of Speakerinvited talk
AbstractSarcopenia is an aging-associated progressive loss of muscle mass and strength, and is accelerated by sedative lifestyle and unhealthy diet. Oxidative damage-induced dysfunctional mitochondria are considered as a culprit of muscle wasting during aging. Herein, we aimed to demonstrate whether myricanol (MY), a cyclic diarylheptanoid derived from Chinese bayberry, protects aged mice against muscle wasting through alleviating oxidative damage, and identify the direct protein target. We discovered that MY protects 18-month-old mice against the loss of muscle mass and strength through scavenging ROS accumulation to rebuild the redox homeostasis and alleviating oxidative damage in mitochondrial DNA to rescue the mitochondrial function. Taking advantage of activity-based protein profiling and biophysical assays including cellular thermal shift assay and isothermal titration calorimetry, peroxiredoxin 5, a critical hydrogen peroxide scavenging enzyme in mitochondria, was discovered and validated as the direct target of MY in protecting C2C12 myotubes against oxidative damage. Through activating peroxiredoxin 5, MY reduced ROS accumulation and damaged mitochondrial DNA. Furthermore, MY selectively binds to the residue Cys100 in peroxiredoxin 5 through hydrophobic interactions and enhances its anti-oxidative activity via the formation of intramolecular disulfide bond. Our findings provide an attractive future direction for therapy against Sarcopenia via peroxiredoxin 5.
Source PublicationActa Materia Medica 杂志创刊两周年暨第二届"我药发现"国际创新药物研发高峰论坛
Conference PlaceBeijing, China
Document TypePresentation
CollectionInstitute of Chinese Medical Sciences
Corresponding AuthorLIN LIGEN
AffiliationUniversity of Macau
First Author AffilicationUniversity of Macau
Recommended Citation
GB/T 7714
LIN LIGEN. Myricanol prevents aging-related Sarcopenia via targeting peroxiredoxin 5 and Nampt[Z]. Acta Materia Medica 杂志创刊两周年暨第二届"我药发现"国际创新药物研发高峰论坛
Files in This Item:
There are no files associated with this item.
Related Services
Recommend this item
Bookmark
Usage statistics
Export to Endnote
Google Scholar
Similar articles in Google Scholar
[LIN LIGEN]'s Articles
Baidu academic
Similar articles in Baidu academic
[LIN LIGEN]'s Articles
Bing Scholar
Similar articles in Bing Scholar
[LIN LIGEN]'s Articles
Terms of Use
No data!
Social Bookmark/Share
All comments (0)
No comment.
 

Items in the repository are protected by copyright, with all rights reserved, unless otherwise indicated.